Cargando…
UPPER RESPIRATORY TRACT INFECTION
Upper respiratory tract infection (URI) is a general term for a heterogeneous group of illnesses caused by numerous etiologic agents that affect the mucosal lining of the upper respiratory tract, including the middle-ear cavity and paranasal sinuses. URIs are primarily caused by viruses, rhinoviruse...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204877/ http://dx.doi.org/10.1016/B0-12-370879-6/00416-6 |
_version_ | 1783530138228490240 |
---|---|
author | Heikkinen, T. Ruuskanen, O. |
author_facet | Heikkinen, T. Ruuskanen, O. |
author_sort | Heikkinen, T. |
collection | PubMed |
description | Upper respiratory tract infection (URI) is a general term for a heterogeneous group of illnesses caused by numerous etiologic agents that affect the mucosal lining of the upper respiratory tract, including the middle-ear cavity and paranasal sinuses. URIs are primarily caused by viruses, rhinoviruses being the most common etiological agents. Respiratory viruses transmit easily via direct contact or aerosols. The incidence of URI is highest in children who suffer 6–8 infections per year. The main symptoms of URI are nasal blockage and discharge, sneezing, sore throat, and cough. Fever occurs variably, most commonly in children. Viral URIs often predispose to bacterial complications. Acute otitis media is the most common complication in children, whereas sinusitis and pneumonia are more frequent in adults and the elderly. The treatment of URI is mainly symptomatic because specific antivirals are available only for influenza viruses. Antibiotics have no efficacy for viral URI but are commonly used for treating acute otitis media and sinusitis. Most URIs are self-limited illnesses with an average duration of 7–10 days and an excellent prognosis. |
format | Online Article Text |
id | pubmed-7204877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
record_format | MEDLINE/PubMed |
spelling | pubmed-72048772020-05-07 UPPER RESPIRATORY TRACT INFECTION Heikkinen, T. Ruuskanen, O. Encyclopedia of Respiratory Medicine Article Upper respiratory tract infection (URI) is a general term for a heterogeneous group of illnesses caused by numerous etiologic agents that affect the mucosal lining of the upper respiratory tract, including the middle-ear cavity and paranasal sinuses. URIs are primarily caused by viruses, rhinoviruses being the most common etiological agents. Respiratory viruses transmit easily via direct contact or aerosols. The incidence of URI is highest in children who suffer 6–8 infections per year. The main symptoms of URI are nasal blockage and discharge, sneezing, sore throat, and cough. Fever occurs variably, most commonly in children. Viral URIs often predispose to bacterial complications. Acute otitis media is the most common complication in children, whereas sinusitis and pneumonia are more frequent in adults and the elderly. The treatment of URI is mainly symptomatic because specific antivirals are available only for influenza viruses. Antibiotics have no efficacy for viral URI but are commonly used for treating acute otitis media and sinusitis. Most URIs are self-limited illnesses with an average duration of 7–10 days and an excellent prognosis. 2006 2006-05-13 /pmc/articles/PMC7204877/ http://dx.doi.org/10.1016/B0-12-370879-6/00416-6 Text en Copyright © 2006 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Heikkinen, T. Ruuskanen, O. UPPER RESPIRATORY TRACT INFECTION |
title | UPPER RESPIRATORY TRACT INFECTION |
title_full | UPPER RESPIRATORY TRACT INFECTION |
title_fullStr | UPPER RESPIRATORY TRACT INFECTION |
title_full_unstemmed | UPPER RESPIRATORY TRACT INFECTION |
title_short | UPPER RESPIRATORY TRACT INFECTION |
title_sort | upper respiratory tract infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204877/ http://dx.doi.org/10.1016/B0-12-370879-6/00416-6 |
work_keys_str_mv | AT heikkinent upperrespiratorytractinfection AT ruuskaneno upperrespiratorytractinfection |